Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) Operating Margin: 2023-2024

Historic Operating Margin for Artiva Biotherapeutics (ARTV) over the last 1 years, with Mar 2024 value amounting to -5,773.71%.

  • Artiva Biotherapeutics' Operating Margin was N/A to -5,773.71% in Q1 2024 from the same period last year, while for Mar 2024 it was -110.22%, marking a year-over-year change of. This contributed to the annual value of -26,805.58% for FY2024, which is 2671400.00% down from last year.
  • According to the latest figures from Q1 2024, Artiva Biotherapeutics' Operating Margin is -5,773.71%, which was down 1,033.52% from -509.36% recorded in Q4 2023.
  • Artiva Biotherapeutics' Operating Margin's 5-year high stood at 40.56% during Q3 2023, with a 5-year trough of -5,773.71% in Q1 2024.
  • Over the past 2 years, Artiva Biotherapeutics' median Operating Margin value was -1,147.96% (recorded in 2023), while the average stood at -2,007.27%.